Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Heimann H, Bornfeld N, Vij O, Coupland SE, Bechrakis NE, Kellner U et al. Vasoproliferative tumours of the retina. Br J Ophthalmol 2000; 84 (10): 1162–1169.
Damato B . Vasoproliferative retinal tumour. Br J Ophthalmol 2006; 90: 399–400.
Gordon MS, Cunningham D . Managing patients treated with bevacizumab combination therapy. Oncology 2005; 69: 25–33.
Author information
Authors and Affiliations
Corresponding author
Additional information
Proprietary interests: None
Rights and permissions
About this article
Cite this article
Kenawy, N., Groenwald, C. & Damato, B. Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin). Eye 21, 893–894 (2007). https://doi.org/10.1038/sj.eye.6702782
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6702782
This article is cited by
-
Ru-106 plaque radiotherapy for vasoproliferative tumors of retina: a 15-year single-center experience
International Ophthalmology (2020)
-
Von Hippel-Lindau-Syndrom
Der Ophthalmologe (2017)
-
Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours
Eye (2014)
-
Histologie bei bilateral asymmetrischem vasoproliferativem Tumor der Retina
Der Ophthalmologe (2012)
-
Retinal vasoproliferative tumours
Eye (2010)
